NCT03282357View on ClinicalTrials.gov

Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China

NACompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

July 27, 2017

Primary Completion Date

July 17, 2018

Study Completion Date

November 30, 2018

Conditions
Correction of the Moderate to Severe Nasolabial Folds
Interventions
DEVICE

Radiesse injectable implant (dermal filler)

Subdermal injection.

DEVICE

Restylane injectable implant (dermal filler)

Subdermal injection

Trial Locations (4)

100034

Peking University First Hospital, Merz Investigational Site #0860003, Beijing

310014

Zhejiang Provincial People's Hospital, Merz Investigational Site #0860005, Hangzhou

410008

Xiangya Hospital Central South University, Department of Aesthetic Plastic Surgery, Merz Investigational Site #'0860007, Hunan

510515

Southern Medical University, Nanfang Hospital, Merz Investigational Site #0860006, Guangzhou

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY

NCT03282357 - Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China | Biotech Hunter | Biotech Hunter